Cargando…

The Current Evidence of Intensity-Modulated Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Intensity-modulated radiotherapy (IMRT) is used worldwide for all tumor sites, for both curing and palliation. While evidence exists for lower normal tissue toxicity, IMRT did not show a definitive survival benefit compared to non-modulated RT. This is the first systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Won Il, Jo, Sunmi, Moon, Ji Eun, Bae, Sun Hyun, Park, Hee Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605127/ https://www.ncbi.nlm.nih.gov/pubmed/37894281 http://dx.doi.org/10.3390/cancers15204914

Ejemplares similares

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results
por: Bae, Sun Hyun, et al.
Publicado: (2017)

A Survey of Stereotactic Body Radiotherapy in Korea
por: Bae, Sun Hyun, et al.
Publicado: (2015)

Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08)
por: Bae, Sun Hyun, et al.
Publicado: (2021)

Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017
por: Bae, Bong Kyung, et al.
Publicado: (2022)

The impact of beam angle configuration of intensity-modulated radiotherapy in the hepatocellular carcinoma
por: Kim, Sung Hoon, et al.
Publicado: (2012)

Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy
por: Son, Seok Hyun, et al.
Publicado: (2016)

Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients?
por: Park, Hee Chul
Publicado: (2016)

Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2015)

Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma
por: Kim, Dong Wook, et al.
Publicado: (2014)

A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma
por: Jo, Sunmi, et al.
Publicado: (2013)

Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
por: Bae, Bong Kyung, et al.
Publicado: (2023)

Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
por: Bae, Sun Hyun, et al.
Publicado: (2023)

Salvage External Beam Radiotherapy after Incomplete Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review
por: Yang, Dae Sik, et al.
Publicado: (2021)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
por: Seo, Young‐Seok, et al.
Publicado: (2016)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy in the Treatment of Breast Cancer: An Updated Review
por: Chang, Jee Suk, et al.
Publicado: (2022)

Magnetic Resonance Imaging for Surveillance of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Kim, Dong Hwan, et al.
Publicado: (2021)

Treatment Outcomes of Helical Intensity-Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma
por: Kong, Moonkyoo, et al.
Publicado: (2013)

Prevalence of Pathogens and Other Microorganisms in Premenopausal and Postmenopausal Women with Vulvovaginal Symptoms: A Retrospective Study in a Single Institute in South Korea
por: Baek, Jong-Chul, et al.
Publicado: (2021)

Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy
por: Kuo, Yu-Cheng, et al.
Publicado: (2011)

Association between Diet Quality and Sarcopenia in Older Adults: Systematic Review of Prospective Cohort Studies
por: Jang, Eun-Hee, et al.
Publicado: (2021)

Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence
por: Kim, Yeon Sil
Publicado: (2017)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
por: Choi, Changhoon, et al.
Publicado: (2019)

Dosimetric evaluation of the skin-sparing effects of 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left breast cancer
por: Jo, In Young, et al.
Publicado: (2016)

Hypofractionated intensity-modulated radiotherapy in patients with localized prostate cancer: a preliminary study
por: Kang, Hye Jin, et al.
Publicado: (2016)

Guillain-Barré syndrome and influenza vaccines: current evidence
por: Fadrique, Rosario Sanz, et al.
Publicado: (2019)

Preliminary results of entire pleural intensity-modulated radiotherapy in a neoadjuvant setting for resectable malignant mesothelioma
por: Hong, Ji Hyun, et al.
Publicado: (2019)

Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)
por: Cha, Hyejung, et al.
Publicado: (2017)

Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
por: Wang, Hongzhi, et al.
Publicado: (2022)

Intensity-modulated radiotherapy—what is it?
por: Taylor, A, et al.
Publicado: (2004)

Compared with intensity‐modulated radiotherapy, image‐guided radiotherapy reduces severity of acute radiation‐induced skin toxicity during radiotherapy in patients with breast cancer
por: Lin, Jang‐Chun, et al.
Publicado: (2018)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2019)

Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
por: Kim, Tae Hyun
Publicado: (2023)

Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Goh, Myung Ji, et al.
Publicado: (2023)

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2018)

Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2015)

Retrospective analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy of postoperative treatment for biliary tract cancer
por: Lee, Hyo Chun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rk54hiqq89ckcntkuet5dt2dru